Latest filing published 14 Jun 2020 for Portage Biotech Inc..
No signal scores available.
This profile gathers the share dealings of Declan Doogan in Portage Biotech Inc. In total, 5 filings cover trades dated from 23 March 2017 to 5 June 2020.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 14 June 2020, reports a transaction in Portage Biotech Inc. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations